Evidence map›Paper›PMID 33563132›Full record

ArticleRedox report : communications in free radical research2021

Redox imbalance induced by docetaxel in the neuroblastoma SH-SY5Y cells: a study of docetaxel-induced neuronal damage.

Lucia Micheli, Giulia Collodel, Elena Moretti, Daria Noto, Andrea Menchiari, Daniela Cerretani, Sergio Crispino, Cinzia Signorini

Open access · goldAbstract read
In one paragraph

Article in Redox report : communications in free radical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Effects ofArhiv za higijenu rada i toksikologiju · 2025
    Article
  2. Article
  3. Trace elements and metal nanoparticles: mechanistic approaches to mitigating chemotherapy-induced toxicity-a review of literature evidence.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Lucia MicheliDepartment of Medical and Surgical Sciences and Neurosciences, University of Siena, Siena, Italy.
Giulia CollodelDepartment of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
Elena MorettiDepartment of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
Daria NotoDepartment of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
Andrea MenchiariDepartment of Business and Law, University of Siena, Siena, Italy.
Daniela CerretaniDepartment of Medical and Surgical Sciences and Neurosciences, University of Siena, Siena, Italy.
Sergio CrispinoScientific Direction ASSO, Siena, Italy.
Cinzia SignoriniDepartment of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
University of Siena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesIn cancer survivors, chemotherapy-associated adverse neurological effects are described as side effects in non-targeted tissue. We investigated the role of redox-imbalance in neuronal damage by a relative low dose of Docetaxel (DTX).

methodsThe neuroblastoma cells (SH-SY5Y cells) were exposed to DTX at a dose of 1.25 nM for 6 h. Antioxidant defenses (i.e. ascorbic acid, glutathione, and catalase) and lipid oxidation products (i.e. F

resultsIn the SH-SY5Y cells, DTX induced a significant reduction of total glutathione ( DISCUSSION: The investigated sublethal dose of DTX, to which non-targeted cells may be exposed throughout the duration of chemotherapy treatment, induces a redox imbalance resulting in a specific modulation of the antioxidant response. This study provides new insights into DTX-induced cellular mechanisms useful for evaluating whether the concomitant use of antioxidants associated with chemotherapy mitigates chemotherapy side effects in cancer survivors.

Indexed as

F2-IsoprostanesNeuroblastomaAntioxidantsApoptosisCell Line, TumorDocetaxelHumansOxidation-ReductionAntioxidantsDocetaxelF2-IsoprostanesApoptosiscellular antioxidantschemobraindocetaxelisoprostanesSH-SY5Y cellstransmission electron microscopytubulin

Identifiers

PMID33563132
PMCPMC7889094
OpenAlexW3127635219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.